BPG is committed to discovery and dissemination of knowledge
Retrospective Study
Copyright: ©Author(s) 2026.
World J Gastrointest Surg. Aug 27, 2026; 18(8): 120623
Published online Aug 27, 2026. doi: 10.4240/wjgs.120623
Table 1 Baseline characteristics overview, n (%)/mean ± SD
Grouping
Significant post-resection fibrosis group (n = 85)
Non-significant post-resection fibrosis group (n = 43)
t/χ2
P value
Age (years)54.42 ± 7.2454.30 ± 6.730.0920.927
Gender1.0060.316
male58 (68.24)33 (76.74)
female27 (31.76)10 (23.26)
BMI (kg/m2)23.87 ± 3.7625.09 ± 4.231.6620.099
Cirrhosis etiology1.2980.730
Viral hepatitis58 (68.24)27 (62.79)
Alcohol-related12 (14.12)7 (16.28)
MASLD7 (8.23)6 (13.95)
Other/mixed8 (9.41)3 (6.98)
Indication for hepatectomy0.3070.858
Hepatocellular carcinoma70 (82.35)34 (79.07)
Benign lesions9 (10.59)6 (13.95)
Other malignancies6 (7.06)3 (6.98)
Extent of resection1.4930.222
Major hepatectomy (≥ 3 segments)33 (38.82)12 (27.91)
Minor hepatectomy (< 3 segments)52 (61.18)31 (72.09)
Child-Pugh class2.1020.147
A59 (69.41)35 (81.40)
B26 (30.59)8 (18.60)
TBIL (μmol/L)18.75 ± 2.1317.09 ± 1.914.304< 0.001
AST (U/L)137.21 ± 38.8492.30 ± 35.966.331< 0.001
ALT (U/L)105.07 ± 25.5896.32 ± 25.411.8310.069
ALP (U/L)112.11 ± 20.43102.50 ± 16.802.6600.009
GGT (U/L)57.96 ± 14.2158.10 ± 10.100.0640.949
PLT (× 109/L)325.87 ± 35.66339.51 ± 30.202.1480.034
WBC (× 109/L)7.95 ± 2.426.90 ± 1.802.5150.013
AAR1.29 ± 0.680.94 ± 0.1812.316< 0.001
APRI1.03 ± 0.190.66 ± 0.2110.084< 0.001
FIB-42.20 ± 0.351.44 ± 0.3212.030< 0.001
SWE (KPa)11.50 ± 3.106.80 ± 2.808.356< 0.001


Write to the Help Desk